Tumor lysis syndrome in a multiple myeloma treated with thalidomide
Ann Oncol
.
2004 Mar;15(3):537.
doi: 10.1093/annonc/mdh116.
Authors
N Fuente
,
J M Mañe
,
R Barcelo
,
A Muñoz
,
T Perez-Hoyos
,
G Lopez-Vivanco
PMID:
14998862
DOI:
10.1093/annonc/mdh116
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antineoplastic Agents / adverse effects*
Humans
Male
Middle Aged
Multiple Myeloma / drug therapy*
Thalidomide / adverse effects*
Tumor Lysis Syndrome / etiology*
Substances
Antineoplastic Agents
Thalidomide